anti-CD3/anti-CAIX bispecific T-cell engager (Micromet)

N/A

Report date: 2026/03/19 16:58:32

Base Information

Drug Nameanti-CD3/anti-CAIX bispecific T-cell engager (Micromet)
Drug Alias NameCAIX-targeting bispecific T-cell engager (Micromet)carbonic anhydrase type IX-targeting BiTE antibody (Micromet)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionCarbonic anhydrase IX modulatorsT cell surface glycoprotein CD3 modulators
TargetsCarbonic anhydrase IXT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Rockville Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Rockville Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A